Champe, Pamela C.; Richard Hubbard Howland; Mary Julia Mycek; Harvey, Richard P. (2006). Pharmacology. Philadelphia: Lippincott William & Wilkins. էջեր 269. ISBN978-0-7817-4118-7.
Ballew JR, Fink GD (September 2001). «Characterization of the antihypertensive effect of a thiazide diuretic in angiotensin II-induced hypertension». Journal of Hypertension. 19 (9): 1601–6. doi:10.1097/00004872-200109000-00012. PMID11564980.
Rejnmark L, Vestergaard P, Pedersen AR, Heickendorff L, Andreasen F, Mosekilde L (January 2003). «Dose-effect relations of loop- and thiazide-diuretics on calcium homeostasis: a randomized, double-blinded Latin-square multiple cross-over study in postmenopausal osteopenic women». Eur. J. Clin. Invest. 33 (1): 41–50. doi:10.1046/j.1365-2362.2003.01103.x. PMID12492451.
Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L (January 2006). «Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide». J. Bone Miner. Res. 21 (1): 163–70. doi:10.1359/JBMR.051003. PMID16355285.
Ali SS, Sharma PK, Garg VK, Singh AK, Mondal SC (Apr 2012). «The target-specific transporter and current status of diuretics as antihypertensive». Fundam Clin Pharmacol. 26 (2): 175–9. doi:10.1111/j.1472-8206.2011.01012.x. PMID22145583.
Schrier, Robert W.; Gross, Peter; Gheorghiade, Mihai; Berl, Tomas; Verbalis, Joseph G.; Czerwiec, Frank S.; Orlandi, Cesare (2006 թ․ նոյեմբերի 16). «Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia». New England Journal of Medicine. 355 (20): 2099–2112. doi:10.1056/NEJMoa065181. hdl:2437/157922. ISSN0028-4793. PMID17105757.
Schrier, Robert W.; Gross, Peter; Gheorghiade, Mihai; Berl, Tomas; Verbalis, Joseph G.; Czerwiec, Frank S.; Orlandi, Cesare (2006 թ․ նոյեմբերի 16). «Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia». New England Journal of Medicine. 355 (20): 2099–2112. doi:10.1056/NEJMoa065181. hdl:2437/157922. ISSN0028-4793. PMID17105757.
nih.gov
pubmed.ncbi.nlm.nih.gov
Ballew JR, Fink GD (September 2001). «Characterization of the antihypertensive effect of a thiazide diuretic in angiotensin II-induced hypertension». Journal of Hypertension. 19 (9): 1601–6. doi:10.1097/00004872-200109000-00012. PMID11564980.
Rejnmark L, Vestergaard P, Pedersen AR, Heickendorff L, Andreasen F, Mosekilde L (January 2003). «Dose-effect relations of loop- and thiazide-diuretics on calcium homeostasis: a randomized, double-blinded Latin-square multiple cross-over study in postmenopausal osteopenic women». Eur. J. Clin. Invest. 33 (1): 41–50. doi:10.1046/j.1365-2362.2003.01103.x. PMID12492451.
Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L (January 2006). «Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide». J. Bone Miner. Res. 21 (1): 163–70. doi:10.1359/JBMR.051003. PMID16355285.
Ali SS, Sharma PK, Garg VK, Singh AK, Mondal SC (Apr 2012). «The target-specific transporter and current status of diuretics as antihypertensive». Fundam Clin Pharmacol. 26 (2): 175–9. doi:10.1111/j.1472-8206.2011.01012.x. PMID22145583.
Schrier, Robert W.; Gross, Peter; Gheorghiade, Mihai; Berl, Tomas; Verbalis, Joseph G.; Czerwiec, Frank S.; Orlandi, Cesare (2006 թ․ նոյեմբերի 16). «Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia». New England Journal of Medicine. 355 (20): 2099–2112. doi:10.1056/NEJMoa065181. hdl:2437/157922. ISSN0028-4793. PMID17105757.
Schrier, Robert W.; Gross, Peter; Gheorghiade, Mihai; Berl, Tomas; Verbalis, Joseph G.; Czerwiec, Frank S.; Orlandi, Cesare (2006 թ․ նոյեմբերի 16). «Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia». New England Journal of Medicine. 355 (20): 2099–2112. doi:10.1056/NEJMoa065181. hdl:2437/157922. ISSN0028-4793. PMID17105757.